Hypertrophic Cardiomyopathy Clinical Trial

Clinical Trial Finder Hypertrophic Cardiomyopathy Trials

Sleep Apnea and Hypertrophic Cardiomyopathy (HCM)

See Locations Near You

Summary

The investigators are trying to find out how common sleep apnea is in hypertrophic cardiomyopathy. The purpose of this study is to see if sleep apnea is common in hypertrophic cardiomyopathy and if its presence is associated with changes in the functioning of the body. The investigators want to determine if sleep apnea is associated with electrical disorders of the heart in patients with hypertrophic cardiomyopathy.

View Full Description

Full Description

Participants will be healthy volunteers or subjects with the diagnosis of hypertrophic cardiomyopathy (HCM). All patients will a undergo a one time; medical history, physical examination, questionnaires, sleep observation in hospital, blood and urine samples, ultrasound scan of the heart, paced breathing test, ultrasound of brachial artery in the arm, MRI of the heart & 48 hour ECG Holter monitoring. Comparison between the normal volunteers and subjects with HCM will be made.

View Eligibility Criteria

Eligibility Criteria

Inclusion criteria:

Adults with a diagnosis of HCM
Able to consent
Non-pregnant
Healthy Controls free of hypertrophic cardiomyopathy and without a definitive family history of hypertrophic cardiomyopathy.

Exclusion criteria:

Decompensated Heart failure at time of enrollment (prior history of HF is not an exclusion criteria)
Severe (known) Chronic obstructive pulmonary disease (COPD) (FEV1 between 30 and 50 percent of normal)
Vulnerable study populations except for minorities (minorities may be targeted to achieve 25% minority recruitment required by the NIH)
Pregnant women
Children

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

520

Study ID:

NCT03327623

Recruitment Status:

Recruiting

Sponsor:

Mayo Clinic

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Mayo Clinic
Rochester Minnesota, 55905, United States More Info
CPL Lab
Contact
507-293-2762
[email protected]
Virend K Somers, MD, PhD
Principal Investigator
Anwar A Chahal, MBChB MRCP
Sub-Investigator
Meghna P Mansukhani, MD
Principal Investigator
Bernard J Gersh, MBChB DPhil
Sub-Investigator
Jeffrey B Geske, MD
Sub-Investigator
Steve R Ommen, MD
Sub-Investigator
Peter A Brady, MD FRCP FHRS
Sub-Investigator
Sean M Caples, DO MSc
Sub-Investigator
Erik K St Louis, MD
Sub-Investigator
Grace Lin, MD
Sub-Investigator
Thomas Olson, PhD
Sub-Investigator
Wolfgand Singer, MD
Sub-Investigator
Shreyas Venkataraman, MBBS
Sub-Investigator
Shahid Karim, MBBS MRCP
Sub-Investigator

How clear is this clinincal trial information?

Study is for people with:

Hypertrophic Cardiomyopathy

Estimated Enrollment:

520

Study ID:

NCT03327623

Recruitment Status:

Recruiting

Sponsor:


Mayo Clinic

How clear is this clinincal trial information?

Clinical Trial Resources

Why I’d Choose a Clinical Trial For Myself
SurvivorNet’s Guide To Clinical Trials: What Are They And Are They Right for You?
Clinical Trials Can be Life-Saving for Some
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider